Loading stock data...

SMS Pharmaceuticals Limited

NSE: SMSPHARMA BSE: SMSPHARMA

NSE
259.50 13.84 (5.63%)

Prev Close

245.66

Open Price

246.15

Volume

218,763

Today Low / High

245.21 / 259.8

52 WK Low / High

176.05 / 390.85

Range

247 - 272

BSE
259.50 13.60 (5.53%)

Prev Close

245.9

Open Price

240.65

Volume

22,106

Today Low / High

240.65 / 259.95

52 WK Low / High

175 / 390

Range

247 - 272

The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 259.5 (target range: 247 - 272), reflecting a change of 13.84 (5.6338%). On the BSE, it is listed at 259.5 (target range: 247 - 272), showing a change of 13.6 (5.5307%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.

01 Oct 246.15 4.80%
30 Sep 244.00 0.68%
29 Sep 251.87 -3.01%
26 Sep 266.05 -5.40%
25 Sep 278.00 -2.65%
24 Sep 288.01 -2.97%
23 Sep 285.29 0.50%
22 Sep 293.80 -3.54%
19 Sep 284.20 2.79%
18 Sep 286.55 -0.41%
17 Sep 287.99 -1.13%
16 Sep 292.80 -2.49%
15 Sep 293.00 -0.35%
12 Sep 296.90 -1.90%
11 Sep 270.50 11.12%
10 Sep 251.00 6.78%
09 Sep 244.28 1.73%
08 Sep 238.37 2.48%
05 Sep 233.60 1.13%
04 Sep 234.98 -0.77%

SMS Pharmaceuticals Limited Graph

SMS Pharmaceuticals Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for SMS Pharmaceuticals Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 259.50, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 259.50 262.10 235.89 - 288.30
264.69 211.75 - 317.63
267.29 187.10 - 347.47
Bearish Scenario 259.50 256.91 231.21 - 282.60
254.31 203.45 - 305.17
251.72 176.20 - 327.23

Overview of SMS Pharmaceuticals Limited

ISIN

INE812G01025

Industry

Drug Manufacturers - General

Vol.Avg

534,432

Market Cap

23,019,608,966

Last Dividend

0.4

Official Website

Visit Website

IPO Date

2007-02-28

DCF Diff

512.63

DCF

-255

Financial Ratios Every Investor Needs

Stock Dividend of SMSPHARMA

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2025-09-22 September 22, 25 0.4 0.4 2025-09-22 2025-10-29
2024-09-23 September 23, 24 0.4 0.4 2024-09-23 2024-10-30
2023-09-22 September 22, 23 0.3 0.3 2023-09-22 2023-10-29
2022-09-22 September 22, 22 0.3 0.3 2022-09-23 2022-10-30
2021-09-22 September 22, 21 0.3 0.3 2021-09-23 2021-10-30

Stock Rating Details for SMSPHARMA

Metric Value Recommendation
Overall Rating D+ Strong Sell
DCF Score 1 Strong Sell
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 2 Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 782.75 Cr 637.83 Cr 144.92 Cr 0.1851 0.00 Cr 0.00 Cr 104.65 Cr 69.14 Cr 8.15 145.22 Cr 0.0883
2024-03-31 709.26 Cr 498.33 Cr 210.94 Cr 0.2974 11.11 Cr 64.22 Cr 134.01 Cr 49.83 Cr 5.89 121.08 Cr 0.0703
2023-03-31 522.05 Cr 393.13 Cr 128.92 Cr 0.2469 8.92 Cr 5.59 Cr 27.26 Cr -7.06 Cr -0.83 59.39 Cr -0.0135
2022-03-31 515.02 Cr 333.59 Cr 181.43 Cr 0.3523 8.39 Cr 4.95 Cr 82.18 Cr 62.22 Cr 7.35 119.53 Cr 0.1208
2021-03-31 560.82 Cr 379.39 Cr 181.43 Cr 0.3235 7.35 Cr 4.11 Cr 98.86 Cr 62.53 Cr 7.39 124.56 Cr 0.1115

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 41.59 Cr 1,152.68 Cr 513.04 Cr 639.6443 Cr 310.76 Cr 269.17 Cr 284.73 Cr 565.52 Cr 0.00 Cr 0.00 Cr 21.57 Cr 324.3686 Cr
2024-03-31 36.04 Cr 1,034.09 Cr 497.76 Cr 536.3289 Cr 280.77 Cr 244.73 Cr 233.70 Cr 464.87 Cr 0.00 Cr 0.00 Cr 10.94 Cr 331.7184 Cr
2023-03-31 7.38 Cr 879.61 Cr 419.08 Cr 460.5252 Cr 254.07 Cr 246.69 Cr 223.50 Cr 443.74 Cr 6.55 Cr 0.00 Cr 11.45 Cr 254.9135 Cr
2022-03-31 46.58 Cr 859.50 Cr 389.21 Cr 470.2886 Cr 263.27 Cr 216.69 Cr 251.10 Cr 447.63 Cr 9.29 Cr -0.19 Cr 28.80 Cr 196.4803 Cr
2021-03-31 40.42 Cr 812.21 Cr 401.68 Cr 410.5280 Cr 254.58 Cr 214.16 Cr 137.79 Cr 462.50 Cr 22.62 Cr 0.00 Cr 26.85 Cr 194.0931 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 64.5230 Cr -123.5956 Cr 64.4322 Cr -58.8568 Cr 5.3596 Cr 41.5861 Cr -123.3798 Cr 69.1356 Cr 30.4302 Cr -3.3861 Cr -51.0313 Cr
2024-03-31 50.1247 Cr -52.0720 Cr 30.6790 Cr -2.0353 Cr 28.7317 Cr 36.0395 Cr -52.1600 Cr 49.8260 Cr 27.5298 Cr -2.5396 Cr -10.1984 Cr
2023-03-31 22.4500 Cr -29.6861 Cr -31.9689 Cr -7.4707 Cr -39.2050 Cr 7.3778 Cr -29.9207 Cr 5.3491 Cr -34.3788 Cr -2.5396 Cr 27.5981 Cr
2022-03-31 40.2337 Cr -27.1530 Cr -6.9210 Cr 12.9863 Cr 6.1597 Cr 46.5828 Cr -27.2474 Cr 68.4991 Cr 9.4075 Cr -2.5395 Cr -113.3102 Cr
2021-03-31 90.4534 Cr -151.5923 Cr 92.0178 Cr -61.2956 Cr 30.8789 Cr 40.4231 Cr -151.7490 Cr 91.1198 Cr 88.4584 Cr 0.0000 Cr -8.5871 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-06-30 196.05 Cr 130.70 Cr 65.35 Cr 0.3333 29.62 Cr 20.49 Cr 2.31 39.96 Cr 0.1045
2025-03-31 248.20 Cr 208.59 Cr 39.61 Cr 0.1596 32.17 Cr 20.32 Cr 2.39 42.23 Cr 0.0819
2024-12-31 173.35 Cr 106.24 Cr 67.11 Cr 0.3871 24.51 Cr 18.24 Cr 2.15 35.34 Cr 0.1052
2024-09-30 196.75 Cr 137.69 Cr 59.06 Cr 0.3002 22.84 Cr 14.10 Cr 1.67 32.77 Cr 0.0717
2024-06-30 164.45 Cr 131.42 Cr 33.03 Cr 0.2008 25.13 Cr 16.48 Cr 1.95 34.88 Cr 0.1002

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-03-31 41.59 Cr 0.00 Cr 41.59 Cr 203.23 Cr 284.73 Cr 554.47 Cr 565.52 Cr 1,152.68 Cr 513.04 Cr
2024-12-31 0.00 Cr 0.00 Cr 9.07 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -563.55 Cr
2024-09-30 8.90 Cr 11.99 Cr 20.89 Cr 213.38 Cr 315.27 Cr 581.94 Cr 518.41 Cr 1,134.73 Cr 571.18 Cr
2024-06-30 -36.20 Cr 72.41 Cr 36.20 Cr 0.00 Cr 0.00 Cr 36.20 Cr 0.00 Cr 0.00 Cr -536.33 Cr
2024-03-31 36.20 Cr 3.44 Cr 36.20 Cr 236.23 Cr 233.70 Cr 533.89 Cr 464.87 Cr 1,034.09 Cr 497.76 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2024-12-31 18.24 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 14.10 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 16.48 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 17.28 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-12-31 11.48 Cr 16.02 Cr 0.00 Cr 0.00 Cr 16.02 Cr 48.94 Cr 32.92 Cr 0.00 Cr 16.02 Cr

Splits History

Date Label Split Ratio
2015-12-17 December 17, 15 10:1

Similar Stocks: Drug Manufacturers - General

Company Name Symbol Price Market Cap Volume
Cipla Limited CIPLA ₹1,511.60 ₹1,221,000,999,306.00 ₹1,000,262.00
Abbott India Limited ABBOTINDIA ₹29,875.00 ₹634,822,867,375.00 ₹6,602.00
GlaxoSmithKline Pharmaceuticals Limited GLAXO ₹2,700.00 ₹457,396,291,800.00 ₹46,082.00
Gland Pharma Limited GLAND ₹1,975.60 ₹325,492,789,279.00 ₹97,264.00
Pfizer Limited PFIZER ₹5,147.00 ₹235,463,396,459.00 ₹381,759.00
Sanofi India Limited SANOFI ₹4,701.50 ₹108,275,394,552.00 ₹12,860.00
Marksans Pharma Limited MARKSANS ₹167.30 ₹75,814,294,706.00 ₹532,205.00

Key Executives

Assistant General Manager of HR and Legal
Mr. Y. Nagarjuna Rao B.Com

Gender: male

Year Born: 1964

Chairman & MD
Mr. Ramesh Babu Potluri

Gender: male

Year Born: 1958

Company Secretary & Compliance Officer
Mr. Tumma Thirumalesh

Gender: male

Year Born:

Head of HRD and General Manager of Purchases
Mr. Potluri Ravi Kumar

Gender: male

Year Born: 1962

Executive Director
Mr. Vamsi Krishna Potluri

Gender: male

Year Born: 1988

Chief Financial Officer
Mr. Lakshmi Narayana Tammineedi

Gender: male

Year Born:

FAQs about SMS Pharmaceuticals Limited

Who is the CEO of the company?

The CEO is Ramesh Babu Potluri.

What is the current market price of the stock?

The current price is ₹259.50.

What is the 52-week price range?

The range is ₹176.05-390.85.

What is the market capitalization of the company?

The market capitalization is ₹2,301.96 crores.

What is the dividend yield?

The dividend yield is 0.15%.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 31.47.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of SMS Pharmaceuticals Limited (ISIN: INE812G01025) is a leading Drug Manufacturers - General in India. With a market capitalization of ₹2,301.96 crores and an average daily volume of 534,432 shares, it operates in the Drug Manufacturers - General. The company last declared a dividend of ₹0.4.